Consumer AI health tools are sold on the premise of democratizing medical insight — giving individuals access to analytical capacity previously available only in clinical settings. What the launch materials for Meta's Muse Spark did not surface is what happened when a Wired reporter asked the medical experts she had consulted whether they would actually use the product on themselves [3]. They would not. The refusal was not principled objection; it was the considered judgment of people who understand the tool's actual performance envelope and have decided it does not…